Prot# LBSL99: A Multi-Center, Open-Label, Continuation Trial of LymphoStat-B Antibody (Monoclonal Anti-BLyS Antibody) in Subjects with Systemic Lupus Erythematosus (SLE) Who Completed the Phase 2 Protocol LBSL02

Project: Research project

Project Details

StatusFinished
Effective start/end date8/26/05 → 11/1/14

Funding

  • Human Genome Sciences, Inc. (LBSL99)